Scinovex
articleTop 1% cited

Antithrombotic Therapy for VTE Disease

CHEST Journal · 2016 · Vol. 149(2) · pp. 315–352
Clive KearonElie A. AklJoseph OrnelasAllen J. BlaivasDavid JiménezHenri BounameauxMenno V. HuismanChristopher S. KingTimothy A. MorrisNamita SoodScott M. StevensJanine VintchPhilip WellsScott C. WollerLisa K. Moores
Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesCardiac tumors and thrombiMedicineEdoxabanRivaroxabanApixabanDabigatranVitamin K antagonistPulmonary embolismLow molecular weight heparinDeep veinInternal medicine

MeSH terms

Drug Administration ScheduleFibrinolytic AgentsHumansSocieties, MedicalEvidence-Based MedicineInternational Normalized RatioVenous Thrombosis

Funding

  • American College of Chest Physicians
Citations
4,737
FWCI
504.41
field-weighted impact
References
619
Percentile
100%
vs. same field & year
Citations per year
References
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
Journal of Clinical Epidemiology · 2011 · 2,800 citations
Cerebral venous thrombosis: an update
The Lancet Neurology · 2007 · 1,218 citations
Oral Anticoagulant Therapy
CHEST Journal · 2012 · 1,489 citations
Pulmonary endarterectomy: experience and lessons learned in 1,500 cases
The Annals of Thoracic Surgery · 2003 · 764 citations
GRADE guidelines: 8. Rating the quality of evidence—indirectness
Journal of Clinical Epidemiology · 2011 · 1,829 citations
Derivation and Validation of a Prognostic Model for Pulmonary Embolism
American Journal of Respiratory and Critical Care Medicine · 2005 · 1,235 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.